Skip to main content
. 2023 Nov 10;14(4):703–709. doi: 10.25259/JNRP_76_2023

Table 3:

Clinical features of stroke in the study population.

Clinical features Total (N=52) n(%) Stroke types P-valueb
Hemorrhagic (N=15) n(%) Ischemic (N=37) n(%)
Hemiparesis 44 (84.6) 14 (93.3) 30 (81.1) 0.412
Headache 18 (34.6) 3 (20.0) 15 (40.5) 0.158c
Vomiting 5 (9.6) 1 (6.7) 4 (10.8) 1.000
Altered sensorium 33 (63.5) 11 (73.3) 22 (59.5) 0.347
Seizures 9 (17.3) 6 (40.0) 3 (8.1) 0.012
Fever 7 (13.5) 0 (0.0) 7 (18.9) 0.093
Aphasia 22 (42.3) 6 (40.0) 16 (43.2) 0.830c
Dysarthria 15 (28.8) 5 (33.3) 10 (27.0) 0.740
Dizziness 3 (5.8) 1 (6.7) 2 (5.4) 1.000
Slurred speech 32 (61.5) 8 (53.3) 24 (69.4) 0.439c
Ataxia 9 (17.3) 2 (13.3) 7 (18.9) 0.712
Blurred vision 3 (5,8) 1 (6.7) 2 (5.4) 1.000
Restlessness 2 (3.8) 0 (0.0) 2 (5.4) 0.581
Dysphagia 1 (1.9) 0 (0.0) 1 (2.7) 1.000
CN VII palsy 32 (61.5) 8 (53.3) 24 (69.4) 0.439c

Bold indicates statistically significant P-value, bFisher’s exact test, cChi-square test. CN: Cranial nerve, N: Number, n: Frequency. All values are stated in numbers (percentages) unless otherwise stated